Artificial Intelligence-Driven Cost Savings from Emergency Department Chest Pain Patient Evaluation: A Monte Carlo Simulation.
7 affiliations
- 1Harvard Medical School, Brigham and Women's Hospital, Department of Emergency Medicine, Boston, Massachusetts.
- 2Harvard Medical School, Massachusetts General Hospital and Brigham and Women's Hospital, Department of Emergency Medicine, Boston, Massachusetts.
- 3Wake Forest University School of Medicine, Winston-Salem, North Carolina.
- 4Massachusetts General Hospital, Department of Cardiology, Boston, Massachusetts.
- 5Massachusetts General Hospital, Department of Gastroenterology, Boston, Massachusetts.
- 6University of Basel, University Hospital Basel, Department of Cardiology, Basel, Switzerland.
- 7Maastricht University Medical Centre, Department of Cardiology, Maastricht, The Netherlands.
Abstract
Introduction
Chest pain patients presenting to the emergency department (ED) often require risk stratification through stress testing, which may necessitate hospitalization. This practice contributes to ED crowding by occupying beds with low-risk patients who may derive limited benefit from testing, thereby increasing bed occupancy, prolonging ED boarding times, amplifying crowding, and resource strain. Use of an artificial intelligence (AI)-driven clinical decision support tool improves the detection of obstructive coronary artery disease and focuses diagnostic testing on those most likely to benefit.Methods
We created a Monte Carlo simulation informed by available published inputs and ran 1,000 trials to estimate the national impact of using an AI-driven decision-support tool to reduce avoidable downstream cardiac testing among eligible U.S. ED patients with chest pain. Model inputs included patient demographics, chest pain history, electrocardiogram (ECG) findings, medication use, and lab values (including some nonroutine tests). Our primary outcome was U.S. annual cost savings from reclassifying eligible ED patients using an AI-driven decision-support tool. Secondary outcomes included reductions in short-stay hospitalizations, cancer cases, and cancer deaths due to averted radiation exposure.Results
Universal adoption of an AI-driven decision-support tool was estimated to save a mean (standard deviation) of $675 million ($340 million) by avoiding 688,000 (147,000) downstream cardiac diagnostic tests. This resulted in annual decreases of 537,000 (115,000) hospitalizations, 8.30 million (1.96 million) bed hours, 490 (150) new cancer diagnoses, and 250 (80) cancer deaths.Conclusion
Assuming similar recategorization of patients seen in a European outpatient cohort, widespread adoption of an AI-driven clinical decision-support tool to evaluate U.S. ED patients with suspected obstructive coronary disease could yield substantial benefits by reducing avoidable downstream cardiac testing. By accurately identifying patients who do not require urgent diagnostics, this approach could help mitigate crowding, relieve resource strain, and improve patient flow-supporting a more efficient emergency care system.
Related
- Artificial Intelligence Echocardiographic Interpretation in the Emergency Department: Agreement, Interpretation Yield and Reporting Scope
- On-Device ECG and Vital-Sign Prediction of 24-Hour Mortality and Unplanned ICU Admission in Emergency Department Patients: A Retrospective Evaluation of MEDI-AI
- A Mixed Methods Evaluation of a Model of Care for Domestic Violence Within the Emergency Department
- Comparison of three emergency department triage systems among Thai medical students: A randomized three-period crossover simulation study
- Emergency Department Evaluation and Care of Hepatic Encephalopathy: ACEP Expert Panel Recommendations.
BibTeX
@article{baugh2026artificial,
title = {{Artificial Intelligence-Driven Cost Savings from Emergency Department Chest Pain Patient Evaluation: A Monte Carlo Simulation.}},
author = {Christopher W Baugh and Andrew Luo and Christopher Zeuthen and Kian D Samadian and Ricardo E De Armas and Michael Senter-Zapata and Michael J Zellweger and Hans-Peter Brunner-LaRocca},
journal = {The western journal of emergency medicine},
year = {2026},
month = jul,
doi = {10.5811/westjem.56973},
url = {https://europepmc.org/article/MED/42900908},
note = {CC BY},
}
RIS
TY - JOUR
TI - Artificial Intelligence-Driven Cost Savings from Emergency Department Chest Pain Patient Evaluation: A Monte Carlo Simulation.
AU - Christopher W Baugh
AU - Andrew Luo
AU - Christopher Zeuthen
AU - Kian D Samadian
AU - Ricardo E De Armas
AU - Michael Senter-Zapata
AU - Michael J Zellweger
AU - Hans-Peter Brunner-LaRocca
PY - 2026
DA - 2026/07/28
JO - The western journal of emergency medicine
DO - 10.5811/westjem.56973
UR - https://europepmc.org/article/MED/42900908
AB - Introduction Chest pain patients presenting to the emergency department (ED) often require risk stratification through stress testing, which may necessitate hospitalization. This practice contributes to ED crowding by occupying beds with low-risk patients who may derive limited benefit from testing, thereby increasing bed occupancy, prolonging ED boarding times, amplifying crowding, and resource strain. Use of an artificial intelligence (AI)-driven clinical decision support tool improves the detection of obstructive coronary artery disease and focuses diagnostic testing on those most likely to benefit.Methods We created a Monte Carlo simulation informed by available published inputs and ran 1,000 trials to estimate the national impact of using an AI-driven decision-support tool to reduce avoidable downstream cardiac testing among eligible U.S. ED patients with chest pain. Model inputs included patient demographics, chest pain history, electrocardiogram (ECG) findings, medication use, and lab values (including some nonroutine tests). Our primary outcome was U.S. annual cost savings from reclassifying eligible ED patients using an AI-driven decision-support tool. Secondary outcomes included reductions in short-stay hospitalizations, cancer cases, and cancer deaths due to averted radiation exposure.Results Universal adoption of an AI-driven decision-support tool was estimated to save a mean (standard deviation) of $675 million ($340 million) by avoiding 688,000 (147,000) downstream cardiac diagnostic tests. This resulted in annual decreases of 537,000 (115,000) hospitalizations, 8.30 million (1.96 million) bed hours, 490 (150) new cancer diagnoses, and 250 (80) cancer deaths.Conclusion Assuming similar recategorization of patients seen in a European outpatient cohort, widespread adoption of an AI-driven clinical decision-support tool to evaluate U.S. ED patients with suspected obstructive coronary disease could yield substantial benefits by reducing avoidable downstream cardiac testing. By accurately identifying patients who do not require urgent diagnostics, this approach could help mitigate crowding, relieve resource strain, and improve patient flow-supporting a more efficient emergency care system.
SN - 1936-900X
SN - 1936-9018
ER -